| Health/Trend |
 |
|
 |
12ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ ÁøÇàµÈ ¡®HAPPY ÇåÇ÷µ¥ÀÌ¡¯¿¡¼ º¸·ÉÁ¦¾à±×·ì ÀÓÁ÷¿øµéÀÌ ÇåÇ÷À» Çϰí ÀÖ´Ùº¸·ÉÁ¦¾à±×·ìÀÌ ÀÓÁ÷¿øÀ» ´ë»óÀ¸·Î ¡°HAPPY ÇåÇ÷µ¥ÀÌ¡± Ä·ÆäÀÎÀ» ÁøÇàÇß´Ù. ¡°HAPPY ÇåÇ÷µ¥ÀÌ¡± Ä·ÆäÀÎÀº º¸·ÉÁ¦¾à±×·ìÀÇ ÀÓÁ÷¿ø Âü¿© »çȸ°øÇåȰµ¿À¸·Î ¿ÃÇØ 10³â°¸¦ ¸Â¾Ò´Ù. ¿ÃÇØ´Â Áö³ 9ÀÏ ¾È»ê°øÀåÀ» ¡¦
|
|
.jpg) |
24ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ ÁøÇàµÈ È£Áß±¸°¨¼ÒÁõÄ¡·áÁ¦ ¡®´º¶óÆå¡¯ °øµ¿ÆÇ¸Å °è¾à½Ä¿¡¼ º¸·ÉÁ¦¾à ÀÌ»ï¼ö´ëÇ¥(¿ÞÂÊ), GC³ì½ÊÀÚ ÇãÀºÃ¶ ´ëÇ¥(¿À¸¥ÂÊ)°¡ ¼¸í½ÄÀ» ¸¶Ä¡°í ±â³ä»çÁøÀ» Âï°íÀÖ´Ù.º¸·ÉÁ¦¾àÀº GC³ì½ÊÀÚ¿Í Áö³ 24ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ È£Áß±¸°¨¼ÒÁõÄ¡·áÁ¦ ¡®´º¶óÆå¡¯ÀÇ °øµ¿ÆÇ¸Å °è¾à½ÄÀ» ÁøÇàÇß´Ù°í 25ÀÏ ¹àÇû´Ù¡¦
|
 |
11ÀÏ ½ºÆäÀÎ ¸¶µå¸®µå ÀÌÆä¸¶ ÄÁº¥¼Ç¼¾ÅÍ¿¡¼ °³ÃÖµÈ ¼¼°èÀǾàǰÀü½Ãȸ ÇöÀå¿¡¼ ÁøÇà µÈ °è¾à ¼¸í½Ä¿¡¼ º¸·ÉÁ¦¾à ±Û·Î¹ú¼¼ÀÏÁîÆÀ ¾È¿µ¹Î ´ë¸®, Çѱ¹ÀǾàǰ¼öÃâÀÔÇùȸ ¿ÀÀå¼® ȸÀå, º¸·ÉÁ¦¾à ±Û·Î¹ú¼¼ÀÏÁîÆÀ ¹ÚÀç·Ï ÀÌ»ç, Àεà¾î¸ÞµðÄ® Á¶³ª½º ¾È°¡¶ó µöÆÄ¶ô(Jonas angara Depalac) ¾àÁ¦ÃÖ°íÃ¥ÀÓÀÚ(chief pharmacist, Hea¡¦
|
 |
Áö³ 22ÀÏ Áß±¹ º£ÀÌ¡ ÀÎÅͳ׼ųΠÄÁº¥¼Ç¼¾ÅÍ¿¡¼ °³ÃÖµÈ 2018¼¼°è°íÇ÷¾ÐÇÐȸ ¡®ÇǸ¶»ç¸£Åº ½ÉÆ÷Áö¾ö¡¯¿¡¼ ¿¬¼¼´ë ¹Ú¼ºÇÏ ±³¼ö°¡ ¡®°íÇ÷¾Ð °ü¸®¿¡¼ ÇǸ¶»ç¸£Åº/¾Ï·ÎµðÇÉ(µàÄ«ºê) ´ÜÀÏÁ¤ º¹ÇÕÁ¦ÀÇ À¯ÀÍÇÑ È¿°ú¡¯¶ó´Â ÁÖÁ¦·Î µàÄ«ºê ÀÓ»ó ½ÃÇè °á°ú¸¦ ¼Ò°³Çϰí ÀÖ´Ù. º¸·ÉÁ¦¾à(´ëÇ¥ ÃÖÅÂÈ«)ÀÌ Áö³ 20ÀϺÎÅÍ 23ÀϱîÁö¡¦
|
 |
8¿ù 8ÀÏ º¸·ÉÁ¦¾à º»»ç¿¡¼ ÁøÇàµÈ ³×½ºÇÁ ¹× ·¹±×ÆÄ¶ó ÄÚÇÁ·Î¸ð¼Ç °è¾à½Ä¿¡¼ º¸·ÉÁ¦¾à ÃÖÅÂÈ« »çÀå (¿ÞÂÊ)°ú Çѱ¹Äì¿ÍÇÏÄڱ⸰ ³ªÁ¾Ãµ »çÀå (¿À¸¥ÂÊ)ÀÌ °è¾à¼¿¡ ¼¸í ÈÄ ¾Ç¼ö¸¦ Çϰí ÀÖ´Ù.¡®º¸·ÉÁ¦¾à(»çÀå ÃÖÅÂÈ«)¡¯°ú ¡®Çѱ¹Äì¿ÍÇÏÄڱ⸰ (»çÀå ³ªÁ¾Ãµ)¡¯Àº 9¿ù 1ÀϺÎÅÍ ¸¸¼º½ÅÀ庴(CKD)ȯÀÚ¿¡¼ ³ªÅ¸³ª´Â ºóÇ÷¿¡ ´ëÇÑ ¡¦
|
 |
Dignitaries, including Boryung Pharmaceutical Group Kim Seung-ho, Boryung Pharmaceutical President Choi Tae-hong, Zuellig Pharma Senior Vice President George Eassey, and John Hoeft, vice president of marketing excellence at ZuelligPharman. attend a ceremony to launch Kanarb in Singapore on July 28. ¡¦
|
 |
President Lee Woo-suk of Kolon Tissue Gene speaks at a news conference at the Kolon One & Only Tower in Magok-dong, western Seoul, on July 10 to celebrate the nation¡¯s approval of ¡°Invossa,¡± Korea¡¯s first gene-therapy drug for treating osteoarthritis. (Photos: Kolon Group)¡°If Invossa, Korea¡¦
|
 |
Boryung Pharmaceutical Group Chairman Kim Seung-ho, Boryung Pharmaceutical President Choi Tae-hong, and President Choi Sung-joon of Boryung Pharmaceutical Seoul Research Institute, along with other executives and staff, participate in a ceremony to celebrate the fifth anniversary of the establishmen¡¦
|
 |
Director Paik Nam-sun of Ewha Womans¡¯ University Cancer Center for Women, who chairs a session on healthy aging life habits and health changes, part of an academic seminar, sponsored by the Healthy Aging Society. (Photo: Director Paik Nam-sun of Ewha Womans¡¯ University Cancer Center for Women)A vi¡¦
|
 |
11¿ù 30ÀÏ aT¿¡¼ °³ÃÖµÈ ´ëÇѹα¹ ½Äǰ¹Ú¶÷ȸ¿¡ ´ëÇѹα¹ õ³âÃÊ ¸í°¡ ³ó¾÷¹ýÀÎ ÁÖ½Äȸ»ç ºÀȲÀÌ Àü½Ãȸ¿¡ Âü°¡ÇÏ¿© ¼ÒºñÀڵ鿡°Ô ¸¹Àº È£ÀÀÀ» ¾ò¾ú´Ù.ºÀȲÀº °æ³² »êû±º Áö¸®»ê ûÁ¤Áö¿ª¿¡¼ À¯±â³ó Àç¹è¹æ½ÄÀ¸·Î õ³âÃʸ¦ Á÷Á¢ Àç¹è ¹× °¡°ø»ý»êÀ» Çϰí ÀÖ´Â À¯¸ÁÇÑ ³ó¾÷¹ýÀÎÀÌ´Ù.Á¤ºÎ¿Í »êû±º¿¡¼´Â ³ó¾÷ÀÇ¡¦
|
|
|
|
 |
A bird¡¯s eye-view of a project to build the planned National AI Computing Center in Haenam, Jeollanam-do. Samsung SDS was the sole bidder of the project. (Photo: Solaseado)Announcing the outcomes of a third bidding on the National AI Computing Cente¡¦
|
 |
A staff member with KGC explains about standardized ingredients of the brand G1899 at the Supply Side Global 2025 that took place in Las Vegas, the United States, from Oct. 29 to Oct. 30. (Photos: KGC)Korea Ginseng Corp. (KGC) has entered the global ¡¦
|
 |
Chairman Shin Dong-bin of Lotte Group. (Photos: Lotte Group)Chmn. Shin Dong-bin of Lotte Business Group carried out a sweeping reshuffle, forcing all vice chairmen to resign from their positions. Twenty CEOs, almost one-third of the CEOs of the ¡¦
|
 |
CJ Group Chairman Lee Jay-hyun poses for a photo with UAE Media Council Chairman Abdullah Al Hamed in the United Arab Emirates on Dec. 9.CJ Group Chairman Lee Jay-hyun successfully carried out his global field-oriented management initiative in 2025, ¡¦
|
|
|